Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.

Stroopinsky D, Rosenblatt J, Ito K, Mills H, Yin L, Rajabi H, Vasir B, Kufe T, Luptakova K, Arnason J, Nardella C, Levine JD, Joyce RM, Galinsky I, Reiter Y, Stone RM, Pandolfi PP, Kufe D, Avigan D.

Cancer Res. 2013 Sep 1;73(17):5569-79. doi: 10.1158/0008-5472.CAN-13-0677. Epub 2013 Jul 18.

2.

Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.

Rosenblatt J, Avivi I, Vasir B, Uhl L, Munshi NC, Katz T, Dey BR, Somaiya P, Mills H, Campigotto F, Weller E, Joyce R, Levine JD, Tzachanis D, Richardson P, Laubach J, Raje N, Boussiotis V, Yuan YE, Bisharat L, Held V, Rowe J, Anderson K, Kufe D, Avigan D.

Clin Cancer Res. 2013 Jul 1;19(13):3640-8. doi: 10.1158/1078-0432.CCR-13-0282. Epub 2013 May 17.

3.

Induction of antitumor immunity ex vivo using dendritic cells transduced with fowl pox vector expressing MUC1, CEA, and a triad of costimulatory molecules (rF-PANVAC).

Vasir B, Zarwan C, Ahmad R, Crawford KD, Rajabi H, Matsuoka K, Rosenblatt J, Wu Z, Mills H, Kufe D, Avigan D.

J Immunother. 2012 Sep;35(7):555-69. doi: 10.1097/CJI.0b013e31826a73de.

4.

Lenalidomide enhances anti-myeloma cellular immunity.

Luptakova K, Rosenblatt J, Glotzbecker B, Mills H, Stroopinsky D, Kufe T, Vasir B, Arnason J, Tzachanis D, Zwicker JI, Joyce RM, Levine JD, Anderson KC, Kufe D, Avigan D.

Cancer Immunol Immunother. 2013 Jan;62(1):39-49. doi: 10.1007/s00262-012-1308-3. Epub 2012 Jun 24.

5.

PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.

Rosenblatt J, Glotzbecker B, Mills H, Vasir B, Tzachanis D, Levine JD, Joyce RM, Wellenstein K, Keefe W, Schickler M, Rotem-Yehudar R, Kufe D, Avigan D.

J Immunother. 2011 Jun;34(5):409-18. doi: 10.1097/CJI.0b013e31821ca6ce.

6.

MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop.

Ahmad R, Rajabi H, Kosugi M, Joshi MD, Alam M, Vasir B, Kawano T, Kharbanda S, Kufe D.

Sci Signal. 2011 Feb 15;4(160):ra9. doi: 10.1126/scisignal.2001426.

7.

Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.

Rosenblatt J, Vasir B, Uhl L, Blotta S, Macnamara C, Somaiya P, Wu Z, Joyce R, Levine JD, Dombagoda D, Yuan YE, Francoeur K, Fitzgerald D, Richardson P, Weller E, Anderson K, Kufe D, Munshi N, Avigan D.

Blood. 2011 Jan 13;117(2):393-402. doi: 10.1182/blood-2010-04-277137. Epub 2010 Oct 28.

8.

Survival of human multiple myeloma cells is dependent on MUC1 C-terminal transmembrane subunit oncoprotein function.

Yin L, Ahmad R, Kosugi M, Kufe T, Vasir B, Avigan D, Kharbanda S, Kufe D.

Mol Pharmacol. 2010 Aug;78(2):166-74. doi: 10.1124/mol.110.065011. Epub 2010 May 5.

9.

Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28.

Rosenblatt J, Wu Z, Vasir B, Zarwan C, Stone R, Mills H, Friedman T, Konstantinopoulos PA, Spentzos D, Ghebremichael M, Stevenson K, Neuberg D, Levine JD, Joyce R, Tzachanis D, Boussiotis V, Kufe D, Avigan D.

J Immunother. 2010 Feb-Mar;33(2):155-66. doi: 10.1097/CJI.0b013e3181bed253.

10.

Immunomodulatory effects of vitamin D: implications for GVHD.

Rosenblatt J, Bissonnette A, Ahmad R, Wu Z, Vasir B, Stevenson K, Zarwan C, Keefe W, Glotzbecker B, Mills H, Joyce R, Levine JD, Tzachanis D, Boussiotis V, Kufe D, Avigan D.

Bone Marrow Transplant. 2010 Sep;45(9):1463-8. doi: 10.1038/bmt.2009.366. Epub 2010 Jan 18.

11.

Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.

Raina D, Ahmad R, Joshi MD, Yin L, Wu Z, Kawano T, Vasir B, Avigan D, Kharbanda S, Kufe D.

Cancer Res. 2009 Jun 15;69(12):5133-41. doi: 10.1158/0008-5472.CAN-09-0854. Epub 2009 Jun 2.

13.

Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma.

Avigan DE, Vasir B, George DJ, Oh WK, Atkins MB, McDermott DF, Kantoff PW, Figlin RA, Vasconcelles MJ, Xu Y, Kufe D, Bukowski RM.

J Immunother. 2007 Oct;30(7):749-61.

PMID:
17893567
14.

Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation.

Vasir B, Borges V, Wu Z, Grosman D, Rosenblatt J, Irie M, Anderson K, Kufe D, Avigan D.

Br J Haematol. 2005 Jun;129(5):687-700.

PMID:
15916692
15.

Dendritic cells induce MUC1 expression and polarization on human T cells by an IL-7-dependent mechanism.

Vasir B, Avigan D, Wu Z, Crawford K, Turnquist S, Ren J, Kufe D.

J Immunol. 2005 Feb 15;174(4):2376-86.

16.

Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.

Avigan D, Vasir B, Gong J, Borges V, Wu Z, Uhl L, Atkins M, Mier J, McDermott D, Smith T, Giallambardo N, Stone C, Schadt K, Dolgoff J, Tetreault JC, Villarroel M, Kufe D.

Clin Cancer Res. 2004 Jul 15;10(14):4699-708.

17.

CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation.

Crawford K, Stark A, Kitchens B, Sternheim K, Pantazopoulos V, Triantafellow E, Wang Z, Vasir B, Larsen CE, Gabuzda D, Reinherz E, Alper CA.

Blood. 2003 Sep 1;102(5):1745-52. Epub 2003 Apr 24.

PMID:
12714509
18.

Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets.

Vasir B, Jonas JC, Steil GM, Hollister-Lock J, Hasenkamp W, Sharma A, Bonner-Weir S, Weir GC.

Transplantation. 2001 Apr 15;71(7):924-35.

PMID:
11349728
19.
20.

Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells.

Vasir B, Aiello LP, Yoon KH, Quickel RR, Bonner-Weir S, Weir GC.

Diabetes. 1998 Dec;47(12):1894-903.

PMID:
9836521
21.

Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages.

Gabuzda DH, Li H, Lawrence K, Vasir BS, Crawford K, Langhoff E.

J Acquir Immune Defic Syndr. 1994 Sep;7(9):908-15.

PMID:
7519673
23.
24.

The relevance of pressure changes in transplanted hearts and kidneys in immunosuppressed rats.

Vasir BS, Hohmeier H, Salaman JR.

Transplantation. 1987 May;43(5):619-25.

PMID:
3554652
25.

The influence of immunosuppression on organ pressure measured in rejecting heart and kidney transplants.

Vasir BS, Hohmeier H, Salaman JR.

Transplant Proc. 1987 Feb;19(1 Pt 2):1066. No abstract available.

PMID:
3274279
26.

Use of myocardial pressure measurements to monitor rejection in transplanted hearts.

Griffin PJ, Vasir B, Hohmeier H, Salaman JR.

Transplant Proc. 1987 Feb;19(1 Pt 2):1065. No abstract available.

PMID:
3274278
27.

Intraorgan pressure changes in rejecting kidney, liver, and heart transplants in the rat.

Vasir B, Kamada N, Hohmeier H, Tamaki T, Salaman JR.

Transplantation. 1985 Jul;40(1):17-21.

PMID:
3892792

Supplemental Content

Support Center